On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The 50S ribosomal subunit: a unique drug target
- Why target the 50S ribosomal subunit?
- Analysis of antibacterial market
- Target markets
- Drug resistance mechanisms (1)
- Drug resistance mechanisms (2)
- Intracellular vs. extracellular pathogens
- Sequestration: MRSA abscess
- Sequestration: biofilm development
- Cell surfaces of Gram-positive/negative bacteria
- How do antibiotics gain entry into cells?
- Porins
- Lack of uptake: streptogramin B
- Self-promoted uptake: azithromycin
- Drug modification: inactivation
- Target modifications
- Erm genes of bacteria and producer strains
- 23S mutations conferring linezolid resistance
- 23S mutations conferring macrolide resistance
- Target modifications: rRNA operons
- Target mutations: ribosomal proteins
- Drug efflux
- Major superfamilies of transport proteins
- Illustration of drug efflux through transporters
- General considerations
Topics Covered
- Why target the 50S ribosomal subunit?
- Analysis of antibacterial market
- Mechanisms of drug resistance
- Sequestration
- How do antibiotics gain entry into cells
- Porins
- Lack of uptake
- Self-promoted uptake drug modification
- Target modifications
- Drug efflux
- Major superfamilies of transport proteins
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Sutcliffe, J. (2008, May 15). Antibiotics that target the 50S ribosome subunit: resistance and other considerations [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/CMET1434.Export Citation (RIS)
Publication History
- Published on May 15, 2008
Financial Disclosures
- Dr. Joyce Sutcliffe has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Hide